VTGN icon

VistaGen Therapeutics
VTGN

Overview Fund Trends Analyst Outlook Journalist POV

21 hedge funds and large institutions have $4.68M invested in VistaGen Therapeutics in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

0% less ownership

Funds ownership: 0.34% → 0.33% (-0%)

Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$772K
2
+$65.3K
3
+$39K
4
FAIM
Financial Advocates Investment Management
Washington
+$35K
5
Millennium Management
Millennium Management
New York
+$28K

Top Sellers

1
-$300K
2
-$4.3K
3
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.21M
2
$1.16M
3
$270K
4
$231K
5
$204K
6
$141K
7
$104K
8
$67K
9
$46K
10
$39K
11
$38K
12
$35K
13
$30K
14
$28K
15
$23K
16
$23K
17
$13K
18
$11K
19
$4K
20
$750
21
–